凯普生物：股东云南众合之累计质押2593万股

Group 1 - The core point of the article is that Capbio (SZ 300639) announced the pledge and extension of shares by its major shareholder, Yunnan Zhonghezhi, which may impact the company's stock performance and liquidity [1] - Yunnan Zhonghezhi has pledged a total of 10.45 million shares to Hongta Securities for release and has extended the pledge of 19 million shares, with a total of 25.93 million shares pledged, accounting for 4.13% of the company's total share capital [1] - As of the announcement date, Capbio's market capitalization is 3.8 billion yuan [1] Group 2 - For the first half of 2025, Capbio's revenue composition is as follows: molecular diagnostic products account for 67.65%, medical testing services for 29.07%, and medical service income for 3.27% [1]